Nainesh Parikh, MD, MBA

Cancer Focus:
Bladder Cancer, Cholangiocarcinoma (Bile Duct Cancer), Colon Cancer, Colorectal Cancer, Head and Neck Cancer, Kidney (Renal Cell) Cancer, Liver (Hepatocellular) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

Dr. Parikh’s clinical area of focus is on patients with benign prostatic hyperplasia (BPH), prostate cancer and kidney cancer as well as primary and secondary liver cancer. As a widely recognized expert on the utilization of prostate artery embolization (PAE) for the management of patients with prostate cancer, Dr. Parikh is dedicated to advancing innovative oncologic care and founded the PAE program at Moffitt Cancer Center in 2017 to help men who suffer from decreased urinary function. He has also published several manuscripts on the topic and currently serves as the primary investigator for a clinical trial studying the role of neoadjuvant PAE prior to definitive radiotherapy for men with prostate cancer (https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-20832/). 

Dr. Parikh has also served in several leadership roles for Moffitt Cancer Center and is currently the Vice President, Chief Clinical Expansion and Partnership Officer. In this role he focuses on clinical growth initiatives and partnerships that bring MoffittCare to the community, closer to patients' homes. He previously served as Assistant Chief Medical Officer with a focus on on finance, strategy, digital innovation and clinical partnerships. 

Dr. Parikh earned his undergraduate degree from Columbia University in New York City and subsequently worked as an investment banker on Wall Street. Determined to make a significant impact on the daily lives of patients, he obtained MD and MBA degrees from Tufts University School of Medicine in Boston, MA. He then completed diagnostic radiology residency at NYU Medical Center in New York City, before moving back to Boston to complete a fellowship in Angiography and Interventional Radiology at the Brigham and Women’s Hospital – Harvard Medical School.

Education & Training

Fellowship:

• NYU Medical Center - Body MR
• Brigham and Women's Hospital/Harvard Medical School - Angiography and Interventional Radiology

Residency:

• NYU Medical Center - Diagnostic Radiology

Medical School:

• Tufts University School of Medicine - MD/MBA

Clinical Trial 20832
A Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization in Patients with Localized Prostate Carcinoma and Obstructive Lower Urinary Tract Symptoms
Condition: Genitourinary
Intervention: Radiotherapy ()
Status: Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

• Rostambeigi N, Sapoval M, Bilhim T, McClure T, McWilliams JP, Carnevale FC, Kovács A, Little MW, Bhatia S, Parikh NS, Young SJ, Ayyagari R, Mouli SK, Golzarian J. Standardized Technique for Prostatic Artery Embolization: A Delphi Consensus Study on Optimized Methods and Emerging Concepts. J Vasc Interv Radiol. 2025 Oct.107902. Pubmedid: 41173451.
• Khatri VM, Grass GD, Thapa R, Maun-Garcia L, Latifi K, Naghavi AO, Garg A, Fernandez D, Torres-Roca J, Rishi A, Jazayeri-Moghaddas O, Pow-Sang J, Johnstone PAS, Yamoah K, Parikh N. Neoadjuvant prostate artery embolization prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiation. Clin Transl Radiat Oncol. 2025 Nov.55:101035. Pubmedid: 41122670. Pmcid: PMC12536586.
• Parikh N, Yamoah K, Johnstone P, Torres-Roca J, Pow-Sang J, Fernandez D, Rishi A, Grass GD. Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion. Cancer Control. 2025 Jan.32. Pubmedid: 39876663. Pmcid: PMC11775958.
• Bibok A, Kis B, Parikh N. Prostate Artery Embolization with 4D-CT. Semin Intervent Radiol. 2024 Jun.41(3):302-308. Pubmedid: 39165653. Pmcid: PMC11333114.
• Naghavi AO, Bryant JM, Kim Y, Weygand J, Redler G, Sim AJ, Miller J, Coucoules K, Michael LT, Gloria WE, Yang G, Rosenberg SA, Ahmed K, Bui MM, Henderson-Jackson EB, Lee A, Lee CD, Gonzalez RJ, Feygelman V, Eschrich SA, Scott JG, Torres-Roca J, Latifi K, Parikh N, Costello J. Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma. BMC Cancer. 2024 Apr.24(1):437. Pubmedid: 38594603. Pmcid: PMC11003059.
• Jordan A, Jain AG, Koipallil GK, Reddy M, Chakkoli S, Midha S, Phuoc V, Eatrides J, Erhardt C, Patel AK, Rico J, Visweshar N, Mhaskar R, Parikh N, Laber D, Jaglal M. Can we lower the platelet threshold of ≥ 50 × 109/L for performing a lumbar puncture safely in patients with hematological malignancies?. Ann Hematol. 2023 Mar.102(3):663-668. Pubmedid: 36534146.
• Bibok A, Kis B, Frakes J, Hoffe S, Zhang J, Jain R, Parikh N. Yttrium-90 Radioembolization for Liver-Dominant Metastatic Prostate Cancer: A Case Series. J Vasc Interv Radiol. 2022 Sep.33(9):1061-1065. Pubmedid: 36049841.
• Johnson W, Weekley A, Suz P, Parikh N, El-Haddad G, Mhaskar R, Kis B. Safety of CT-Guided Microwave Ablation of Subcardiac Liver Tumors. Cardiovasc Intervent Radiol. 2022 Nov.45(11):1693-1700. Pubmedid: 35941243.
• Bibok A, Mhaskar R, Jain R, Zhang J, Frakes J, Hoffe S, El-Haddad G, Parikh N, Ahmed A, Fishman MN, Choi J, Kis B. Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study. Cardiovasc Intervent Radiol. 2021 Nov.44(11):1755-1762. Pubmedid: 34312688.
• Peacock J, Sikariam D, Maun-Garcia L, Javedan K, Yamoah K, Parikh N. A Proof-of-Concept Study on the Use of Prostate Artery Embolization Before Definitive Radiation Therapy in Prostate Cancer. Adv Radiat Oncol. 2021 May.6(3):100619. Pubmedid: 33748542. Pmcid: PMC7966837.
• Parikh N, Keshishian E, Manley B, Grass GD, Torres-Roca J, Boulware D, Feuerlein S, Pow-Sang JM, Bagla S, Yamoah K, Bhatia S. Effectiveness and Safety of Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms from Benign Prostatic Hyperplasia in Men with Concurrent Localized Prostate Cancer. J Vasc Interv Radiol. 2021 Jul.32(7):1053-1061. Pubmedid: 33794373.
• Chahoud J, McGettigan M, Parikh N, Boris RS, Iliopoulos O, Rathmell WK, Daniels AB, Jonasch E, Spiess PE. Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease. World J Urol. 2021 Jul.39(7):2409-2415. Pubmedid: 32936333. Pmcid: PMC8101019.
• Parikh N, Acharya V, Bhatia S. Prostate Artery Embolization - Adverse Events and Peri-Procedural Management. Tech Vasc Interv Radiol. 2020 Sep.23(3):100692. Pubmedid: 33308533.
• Makovich Z, Logemann J, Chen L, Mhaskar R, Choi J, Parikh N, El-Haddad G, Kis B. Liver tumor ablation in difficult locations: Microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma. Clin Imaging. 2020 Nov.71:170-177. Pubmedid: 33285405.
• Kayaleh R, Krzyston H, Rishi A, Naziri J, Frakes J, Choi J, El-Haddad G, Parikh N, Sweeney J, Kis B. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study. J Vasc Interv Radiol. 2020 Jul.31(7):1060-1068. Pubmedid: 32534978.
• Gunn AJ, Parikh NS, Bhatia S. Society of Interventional Radiology Quality Improvement Standards on Percutaneous Ablation in Renal Cell Carcinoma. J Vasc Interv Radiol. 2020 Feb.31(2):195-201.e3. Pubmedid: 31917026.
• Parikh N, Keshishian E, Sharma A, Roca M, Manley B, Poch M, Grass GD, Torres-Roca J, Boulware D, Johnstone P, Montejo M, Smith J, Pow-Sang J, Yamoah K. Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis. Adv Radiat Oncol. 2020 Apr.5(5):905-909. Pubmedid: 33083652. Pmcid: PMC7557125.
• Parikh N, Keshishian E, Sharma A, Roca M, Manley B, Poch M, Grass GD, Torres-Roca J, Boulware D, Johnstone P, Montejo M, Smith J, Pow-Sang J, Yamoah K. Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis. Adv Radiat Oncol. 2020 Apr.
• Sweeney J, Parikh N, El-Haddad G, Kis B. Ablation of Intrahepatic Cholangiocarcinoma. Semin Intervent Radiol. 2019 Oct.36(4):298-302. Pubmedid: 31680720. Pmcid: PMC6823041.
• Gangi A, Shah J, Hatfield N, Smith J, Sweeney J, Choi J, El-Haddad G, Biebel B, Parikh N, Arslan B, Hoffe SE, Frakes JM, Springett GM, Anaya DA, Malafa M, Chen DT, Chen Y, Kim RD, Shridhar R, Kis B. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study. J Vasc Interv Radiol. 2018 Aug.29(8):1101-1108. Pubmedid: 30042074. Pmcid: PMC7771272.
• Sweeney J, Parikh N. Inferior vena cava filter placement in a left IVC and drainage into duplicated SVC via hemiazygous continuation. Radiol Case Rep. 2018 Apr.13(2):320-323. Pubmedid: 29904464. Pmcid: PMC5999865.
• Ream JM, Doshi AM, Dunst D, Parikh N, Kong MX, Babb JS, Taneja SS, Rosenkrantz AB. Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer. J Magn Reson Imaging. 2017 May.45(5):1464-1475. Pubmedid: 27649481. Pmcid: PMC5538355.
• Kis B, El-Haddad G, Sheth RA, Parikh NS, Ganguli S, Shyn PB, Choi J, Brown KT. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control. 2017 Jul.24(3). Pubmedid: 28975829. Pmcid: PMC5937250.
• Rosenkrantz AB, Parikh N, Kierans AS, Kong MX, Babb JS, Taneja SS, Ream JM. Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging: How High Should We Go?. Acad Radiol. 2016 Jun.23(6):704-711. Pubmedid: 26992738.
• Parikh N, Ream JM, Zhang HC, Block KT, Chandarana H, Rosenkrantz AB. Performance of simultaneous high temporal resolution quantitative perfusion imaging of bladder tumors and conventional multi-phase urography using a novel free-breathing continuously acquired radial compressed-sensing MRI sequence. Magn Reson Imaging. 2016 Jun.34(5):694-698. Pubmedid: 26740058. Pmcid: PMC4896486.
• Navi BB, Parikh NS, Lerario MP, Merkler AE, Lappin RI, Fahimi J, Iadecola C, Kamel H. Risk of Intracerebral Hemorrhage after Emergency Department Discharges for Hypertension. J Stroke Cerebrovasc Dis. 2016 Jul.25(7):1683-1687. Pubmedid: 27068776. Pmcid: PMC4912410.
• Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H. Stroke Risk and Mortality in Patients With Ventricular Assist Devices. Stroke. 2016 11.47(11):2702-2706. Pubmedid: 27650070. Pmcid: PMC5079813.
• Kierans A, Parikh N, Chandarana H. Recent Advances in MR Hardware and Software. Radiol Clin North Am. 2015 May.53(3):599-610. Pubmedid: 25953292.
• Gaing B, Sigmund EE, Huang WC, Babb JS, Parikh NS, Stoffel D, Chandarana H. Subtype differentiation of renal tumors using voxel-based histogram analysis of intravoxel incoherent motion parameters. Invest Radiol. 2015 Mar.50(3):144-152. Pubmedid: 25387050.
• Parikh N, Friedman KP, Shah SN, Chandarana H. Practical guide for implementing hybrid PET/MR clinical service: lessons learned from our experience. Abdom Imaging. 2015 Aug.40(6):1366-1373. Pubmedid: 25985966. Pmcid: PMC4534342.
• Parikh N, Morris E, Babb J, Wickstrom M, McMenamy J, Sharma R, Schwartz D, Lifshitz M, Kim D. MDCT diagnosis of acute pulmonary embolism in the emergent setting. Emerg Radiol. 2015 Aug.22(4):379-384. Pubmedid: 25573686.

Voted top doctor in Interventional Radiology in Tampa Magazine’s Top Doctors 2025.

Voted top doctor in Interventional Radiology in Tampa Magazine's Top Doctors 2024.